ABBOTT LABORATORIES — Director's Dealing 2004

Apr 27, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-04-23

Reporting Person: REYNOLDS W ANN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-04-23	Common shares without par value	A	1577	$41.20	Acquired	32986	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-04-23	Option (right to buy)	$41.20	A	6699	Acquired	2014-04-22	common shares (6699)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1587	Indirect
Common shares without par value	677	Indirect

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

F2: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions were exempt from Section 16 under Rule 16a-11.

F3: The reporting person disclaims beneficial ownership of all securities held by her husband.

F4: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b). It contains a replacement option feature.